Return to CG30 Overview

Long-acting reversible contraception [CG30]

Measuring the use of this guidance

Recommendation: 1.1.1.1

Women requiring contraception should be given information about and offered a choice of all methods, including long-acting reversible contraception (LARC) methods.

What was measured: Proportion of women, on the register, prescribed emergency hormonal contraception one or more times in the preceding 12 months by the contractor who have received information from the contractor about long acting reversible methods of contraception at the time of or within 1 month of the prescription.
Data collection end: March 2015
89.8%
Area covered: England
Source: Health and Social Care Information Centre. Quality Outcomes Framework.

What was measured: CON003: The percentage of women, on the register, prescribed emergency hormonal contraception one or more times in the preceding 12 months by the contractor who have received information from the contractor about long acting reversible methods of contraception at the time of or within 1 month of the prescription.
Data collection end: March 2016
90.6%
Data collection end: March 2017
92.3%
Area covered: National
Source: Health and Social Care Information Centre. Quality and Outcomes Framework.

What was measured: Proportion of women, on the register, prescribed an oral or patch contraceptive method in the preceding 12 months who have also received information from the contractor about long acting reversible methods of contraception in the preceding 12 months.
Data collection end: March 2018
43.3%
Number that met the criteria: 1104163 / 2552791
Area covered: England
Source: Indicators no longer in QOF (INLIQ)

What was measured: Proportion of women who were using Long Acting Reversible Contraceptives.
Data collection end: March 2018
41%
Number that met the criteria: 327200 / 7926000
Area covered: England
Source: NHS Digital. Statistics on Sexual and Reproductive Health Services.


Recommendation: 1.1.4.2

Healthcare professionals providing contraceptive advice should be able to assess risk for sexually transmitted infections (STIs) and advise testing when appropriate. [2005]

What was measured: Proportion of women who did not have a formal STI risk assessment during their consultation with a GP for an oral contraceptive.
Data collection end: January 2016
92%
Area covered: Local
Source: Russell S, Wiles H (2017) Improving combined contraceptive pill/oral contraceptives prescribing in general practice. BMJ Open Quality 6:3000137. doi:10.1136/bmjoq-2017-000137



 Return to CG30 Overview